Blog
Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Form 8.3 - The Vanguard Group, Inc.: Balanced Commercial Property Trust Limited
Form 8.3 - The Vanguard Group, Inc.: Balanced Commercial Property Trust Limited
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Form 8.3 - The Vanguard Group, Inc.: Britvic plc
Form 8.3 - The Vanguard Group, Inc.: Britvic plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc
Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
EQS-News: APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a voluntary public purchase offer
EQS-News: APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a voluntary public purchase offer
EQS-Adhoc: APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer
EQS-Adhoc: APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer
EQS-News: H&R receives funding approval for climate protection project to reduce CO₂ at Salzbergen site
EQS-News: H&R receives funding approval for climate protection project to reduce CO₂ at Salzbergen site
EQS-News: SNP: Significant Increase of Revenue and Earnings in the Third Quarter – Further Raise of Full-Year Guidance 2024
EQS-News: SNP: Significant Increase of Revenue and Earnings in the Third Quarter – Further Raise of Full-Year Guidance 2024
EQS-Adhoc: SNP Again Raises Outlook for the Full Year 2024
EQS-Adhoc: SNP Again Raises Outlook for the Full Year 2024
Invitation: Straumann Group 2024 third-quarter results webcast
Invitation: Straumann Group 2024 third-quarter results webcast
Funding Circle Plc: Buyback Programme Update
Funding Circle Plc: Buyback Programme Update
Solidcore Resources plc: Investor Relations team update
Solidcore Resources plc: Investor Relations team update
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
EQS-News: clearvise AG signs purchase agreement for a majority stake in a French photovoltaic project with an approved capacity of more than 70 MWp
EQS-News: clearvise AG signs purchase agreement for a majority stake in a French photovoltaic project with an approved capacity of more than 70 MWp
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with good demand in the first nine months of 2024
EQS-News: Drägerwerk AG & Co. KGaA: Dräger with good demand in the first nine months of 2024
EQS-News: Formycon published results of analytical similarity study of biosimilar candidate FYB206 and Keytruda® in peer-reviewed journal Drugs in R&D
EQS-News: Formycon published results of analytical similarity study of biosimilar candidate FYB206 and Keytruda® in peer-reviewed journal Drugs in R&D
Ongoing weak market dynamics impact order intake
Ongoing weak market dynamics impact order intake
EQS-Adhoc: aap Implantate AG: Possible cyber attack on aap
EQS-Adhoc: aap Implantate AG: Possible cyber attack on aap


